Earnings calls

3B Blackbio concall ledger

Every earnings call for 532067 — management tone, guidance, KPIs and promise tracking, quarter by quarter.

532067 · 3 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 01 Jun 2026Call held 01 Jun 2026

532067 Q4 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹142 crConsolidated EBITDA Margin40%Consolidated PAT₹60 cr

Consolidated Revenue ₹142 cr; Consolidated EBITDA Margin 40%; Consolidated PAT ₹60 cr. Consolidated revenue of approximately INR142 crores for FY26.

Read full transcript & analysis

Q3 FY26Published 21 Feb 2026Call held 21 Feb 2026

532067 Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹99.06 cr+53% YoY

Revenue (9M FY26, with Coris) ₹99 cr (+53% YoY). Consolidated revenue for 9M FY26 (with Coris) was INR 99.06 crores, up 52.87% YoY from INR 64.80 crores (without Coris) in 9M FY25.

Read full transcript & analysis

Q1 FY26Published 19 Aug 2025Call held 19 Aug 2025

532067 Q1 FY26 Earnings Call Transcript & Analysis

EBITDA₹16.19 cr+11% YoY

EBITDA ₹16 cr (+11% YoY). Q1 FY26 Sales reached INR 19.96 crores, marking an 18% year-on-year increase.

Read full transcript & analysis